Disease risk: Difference between revisions

From Opasnet
Jump to navigation Jump to search
(→‎Rationale: units from cases/100000py -> cases/py)
Line 71: Line 71:
Basalioma|Whole population|||Morbidity|cases /100000py|125.984|6772|
Basalioma|Whole population|||Morbidity|cases /100000py|125.984|6772|
Leukemia|Whole population|||Morbidity|cases /100000py|10.027|539|Year 2010, cancer register
Leukemia|Whole population|||Morbidity|cases /100000py|10.027|539|Year 2010, cancer register
</t2b>
DALY/a thousands WHO 2002 EU-27 OECD, 22 Population, millions Trachea, bronchus & lung cancers Cardio-vascular diseases Trachea, bronchus & lung cancers Cardio-vascular diseases
<t2b name='DALY in Europe WHO 2002' index="Country,EU-27,OECD22,Population,Trachea bronchus & lung cancers DALY/a thousands,Cardio-vascular diseases DALY/a thousands, Trachea bronchus & lung cancers DALY/a/100 000,Cardio-vascular diseases DALY/a/100 000" obs="(sub)urban 2009-11 PM2.5 mean μg/m3" desc="Description" unit="-">
Austria | 1 | 1 | 8.4 | 27 | 189 | 321 | 2244 | 18.9 |
Belgium | 1 | 1 | 11.0 | 55 | 209 | 499 | 1898 | 17.6 |
Bulgaria | 1 | 0 | 7.3 | 32 | 526 | 435 | 7157 | 31.4 |
Cyprus | 1 | 0 | 0.9 | 1 | 21 | 117 | 2467 | 21.3 |
Czech Republic | 1 | 1 | 10.5 | 52 | 352 | 495 | 3352 | 23.0 |
Denmark | 1 | 1 | 5.6 | 26 | 114 | 461 | 2021 | 14.0 |
Estonia | 1 | 0 | 1.3 | 5 | 65 | 373 | 4852 | 19.5 |
Finland | 1 | 1 | 5.4 | 14 | 122 | 260 | 2266 | 7.3 |
France | 1 | 1 | 65.2 | 243 | 857 | 373 | 1315 | 17.9 |
Germany | 1 | 1 | 81.8 | 354 | 2070 | 433 | 2530 | 16.8 |
Greece | 1 | 1 | 10.8 | 49 | 341 | 453 | 3153 | 19.4 |
Hungary | 1 | 1 | 10.0 | 76 | 410 | 762 | 4113 | 22.6 |
Ireland | 1 | 1 | 4.5 | 12 | 77 | 265 | 1703 | 10.8 |
Italy | 1 | 1 | 60.7 | 238 | 1222 | 392 | 2013 | 21.5 |
Latvia | 1 | 0 | 2.1 | 10 | 130 | 486 | 6318 | 15.1 |
Lithuania | 1 | 0 | 3.0 | 13 | 138 | 429 | 4555 | 12.7 |
Luxembourg | 1 | 1 | 0.5 | 2 | 9 | 381 | 1715 | 15.9 |
Malta | 1 | 0 | 0.4 | 1 | 8 | 240 | 1920 | 13.6 |
Netherlands | 1 | 1 | 16.7 | 73 | 307 | 437 | 1839 | 17.0 |
Norway | 0 | 1 | 5.0 | 15 | 87 | 303 | 1756 | |
Poland | 1 | 1 | 38.5 | 215 | 1226 | 558 | 3181 | 28.2 |
Portugal | 1 | 1 | 10.6 | 29 | 263 | 275 | 2491 | 8.6 |
Romania | 1 | 0 | 21.4 | 92 | 1094 | 430 | 5118 | 18.1 |
Slovakia | 1 | 1 | 5.4 | 19 | 175 | 352 | 3242 | 25.0 |
Slovenia | 1 | 0 | 2.1 | 9 | 51 | 439 | 2485 | 21.5 |
Spain | 1 | 1 | 46.2 | 155 | 670 | 336 | 1450 | 12.5 |
Sweden | 1 | 1 | 9.4 | 23 | 187 | 244 | 1981 | 8.0 |
Switzerland | 0 | 1 | 7.9 | 25 | 116 | 316 | 1465 | |
Turkey | 0 | 1 | 74.8 | 115 | 2082 | 154 | 2785 | |
United Kingdom | 1 | 1 | 62.8 | 230 | 1297 | 366 | 2065 | 13.3 |
All of the above | | | 590.2 | 2210 | 14415 | 374 | 2442 | 17.7 |
EU27 Total | | | 502.6 | 2055 | 12130 | 409 | 2413 | 17.7 |
OECD Europe total | | | 553.1 | 2052 | 12447 | 371 | 2250 | 17.7 |
</t2b>
</t2b>



Revision as of 07:04, 10 June 2015



Question

What are incidence or prevalence rates of different diseases in Finland?

Answer

+ Show code

----#: . Code seems to work, but gives out the yellow errorbox. --Heta 13:02, 27 August 2013 (EEST) (type: truth; paradigms: science: comment)

Rationale

Data

Data from op_fi:Seturi/tautiriski

Population column defines the relevant population subgroup other than age and sex subgroups, which are defined in their respective columns. The numbers of cases are divided by the size of the population (total population even in cases where the cases are from a subgroup only. The population size is estimated at 5375276 in 2010, and this is used as denominator in the incidence calculation.

Disease risk: Difference between revisions(# /100000py, DALY)
ObsTraitPopulationAgeSexResponse metricUnitIncidenceActual casesDescription
1Lung cancerWhole populationMorbiditycases /100000py42.3422276Year 2010 cancer register
2CardiopulmonaryWhole populationMortalitycases /100000py443.51223840
3Total mortalityWhole populationMortalitycases /100000py940.752505682011 data, Tilastokeskus
4Bladder cancerWhole populationMorbiditycases /100000py16.706898Year 2010 cancer register
5Myocardial infarctionWhole populationMorbiditycases /100000py463.19524898
6Ischaemic heart diseaseWhole populationMortalitycases /100000py221.14211887
7CHDWhole populationMortalitycases /100000py221.14211887This is a duplicate of the previous row to match more ERFs
8CHDWhole populationArrythmia mortalitycases /100000py221.14211887This is a duplicate of the previous row to match more ERFs
9AsthmaWhole populationMorbiditycases /100000py270.88814561
10AsthmaWhole population>21Morbiditycases /100000py176.1039466
11AsthmaWhole population<14Morbiditycases /100000py81.2244366
12Pulmonary infectionsWhole population<2MorbidityDALY35
13Otitis mediaWhole population<3MorbidityDALY48
14Lower respiratory symptomsWhole populationMorbiditycases /100000py8985.585483000
15Upper respiratory symptomsWhole populationMorbiditycases /100000py17279.969928846
16Ischaemic heart disease/myocardial infarctionWhole population35-64MMorbiditycases /100000py86.6465535-64v miesten 1. infarktin insidenssi 354/100000 1991-4. Aromaa ym Suomalaisten terveys s155
17CHDWhole population35-64MMorbiditycases /100000py86.6465535-64v miesten 1. infarktin insidenssi 354/100000 1991-4. Aromaa ym Suomalaisten terveys s155. This is a duplicate of the previous row to match more ERFs
18Nasal cancerWhole population20-64Morbiditycases /100000py0.65135Age boundaries are assumed without original data
19COPDWhole population15-64Mortalitycases /100000py20.9661127
20AsthmaWhole population15-64MMorbiditycases /100000py58.0443120
21AsthmaWhole population15-64FMorbiditycases /100000py78.9544244
22CancerWhole populationMorbiditycases /100000py202.40810880
23CancerWhole populationLifetime probabilityprobability1This is used with absolute risk functions such as CSF to get rid of the parameter relative to background
24All skin cancers and basaliomaWhole populationMorbiditycases /100000py163.2858777
25Skin cancerWhole populationMorbiditycases /100000py37.32005
26MelanomaWhole populationMorbiditycases /100000py16.855906
27Carcinoma spinocellulareWhole populationMorbiditycases /100000py20.4451099
28BasaliomaWhole populationMorbiditycases /100000py125.9846772
29LeukemiaWhole populationMorbiditycases /100000py10.027539Year 2010, cancer register

DALY/a thousands WHO 2002 EU-27 OECD, 22 Population, millions Trachea, bronchus & lung cancers Cardio-vascular diseases Trachea, bronchus & lung cancers Cardio-vascular diseases


DALY in Europe WHO 2002(-)
ObsCountryEU-27OECD22PopulationTrachea bronchus & lung cancers DALY/a thousandsCardio-vascular diseases DALY/a thousands Trachea bronchus & lung cancers DALY/a/100 000Cardio-vascular diseases DALY/a/100 000(sub)urban 2009-11 PM2.5 mean μg/m3Description
1Austria 1 1 8.4 27 189 321 2244 18.9
2Belgium 1 1 11.0 55 209 499 1898 17.6
3Bulgaria 1 0 7.3 32 526 435 7157 31.4
4Cyprus 1 0 0.9 1 21 117 2467 21.3
5Czech Republic 1 1 10.5 52 352 495 3352 23.0
6Denmark 1 1 5.6 26 114 461 2021 14.0
7Estonia 1 0 1.3 5 65 373 4852 19.5
8Finland 1 1 5.4 14 122 260 2266 7.3
9France 1 1 65.2 243 857 373 1315 17.9
10Germany 1 1 81.8 354 2070 433 2530 16.8
11Greece 1 1 10.8 49 341 453 3153 19.4
12Hungary 1 1 10.0 76 410 762 4113 22.6
13Ireland 1 1 4.5 12 77 265 1703 10.8
14Italy 1 1 60.7 238 1222 392 2013 21.5
15Latvia 1 0 2.1 10 130 486 6318 15.1
16Lithuania 1 0 3.0 13 138 429 4555 12.7
17Luxembourg 1 1 0.5 2 9 381 1715 15.9
18Malta 1 0 0.4 1 8 240 1920 13.6
19Netherlands 1 1 16.7 73 307 437 1839 17.0
20Norway 0 1 5.0 15 87 303 1756
21Poland 1 1 38.5 215 1226 558 3181 28.2
22Portugal 1 1 10.6 29 263 275 2491 8.6
23Romania 1 0 21.4 92 1094 430 5118 18.1
24Slovakia 1 1 5.4 19 175 352 3242 25.0
25Slovenia 1 0 2.1 9 51 439 2485 21.5
26Spain 1 1 46.2 155 670 336 1450 12.5
27Sweden 1 1 9.4 23 187 244 1981 8.0
28Switzerland 0 1 7.9 25 116 316 1465
29Turkey 0 1 74.8 115 2082 154 2785
30United Kingdom 1 1 62.8 230 1297 366 2065 13.3
31All of the above 590.2 2210 14415 374 2442 17.7
32EU27 Total 502.6 2055 12130 409 2413 17.7
33OECD Europe total 553.1 2052 12447 371 2250 17.7

Calculations

+ Show code

See also

Keywords

References


Related files

<mfanonymousfilelist></mfanonymousfilelist>